145 related articles for article (PubMed ID: 11271259)
1. Effect of ganciclovir prophylaxis on cytomegalovirus-enhanced allograft arteriosclerosis.
Lemström KB; Koskinen PK; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
Transpl Int; 1994; 7 Suppl 1():S383-4. PubMed ID: 11271259
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.
Lemström KB; Bruning JH; Bruggeman CA; Koskinen PK; Aho PT; Yilmaz S; Lautenschlager IT; Häyry PJ
Circulation; 1994 Oct; 90(4):1969-78. PubMed ID: 7923687
[TBL] [Abstract][Full Text] [Related]
3. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection.
Lemström K; Koskinen P; Krogerus L; Daemen M; Bruggeman C; Häyry P
Circulation; 1995 Nov; 92(9):2594-604. PubMed ID: 7586362
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
J Clin Invest; 1993 Aug; 92(2):549-58. PubMed ID: 8394384
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.
Lemström KB; Aho PT; Bruggeman CA; Häyry PJ
Arterioscler Thromb; 1994 Dec; 14(12):2043-52. PubMed ID: 7981194
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat.
Lemström K; Sihvola R; Bruggeman C; Häyry P; Koskinen P
Circulation; 1997 Jun; 95(12):2614-6. PubMed ID: 9193428
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression.
Yilmaz S; Koskinen PK; Kallio E; Bruggeman CA; Häyry PJ; Lemström KB
Kidney Int; 1996 Aug; 50(2):526-37. PubMed ID: 8840282
[TBL] [Abstract][Full Text] [Related]
9. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.
Koskinen P; Lemström K; Bruggeman C; Lautenschlager I; Häyry P
Am J Pathol; 1994 Jan; 144(1):41-50. PubMed ID: 8291611
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis or immunosuppression in rat tracheal allografts.
Tikkanen JM; Kallio EA; Bruggeman CA; Koskinen PK; Lemström KB
Am J Respir Crit Care Med; 2001 Aug; 164(4):672-9. PubMed ID: 11520736
[TBL] [Abstract][Full Text] [Related]
11. Rat cytomegalovirus infection and chronic kidney allograft rejection.
Koskinen PK; Yilmaz S; Kallio E; Bruggeman CA; Häyry PJ; Lemström K
Transpl Int; 1996; 9 Suppl 1():S3-4. PubMed ID: 8959777
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus-enhanced development of transplant arteriosclerosis in the rat; effect of timing of infection and recipient responsiveness.
Hillebrands JL; van Dam JG; Onuta G; Klatter FA; Grauls G; Bruggeman CA; Rozing J
Transpl Int; 2005 Jun; 18(6):735-42. PubMed ID: 15910303
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC.
Bruning JH; Persoons M; Lemström K; Stals FS; De Clercq E; Bruggeman CA
Transpl Int; 1994; 7 Suppl 1():S365-70. PubMed ID: 11271253
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naïve recipients.
Orloff SL; Hwee YK; Kreklywich C; Andoh TF; Hart E; Smith PA; Messaoudi I; Streblow DN
Am J Transplant; 2011 Jan; 11(1):45-55. PubMed ID: 21199347
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection and cardiac allograft vasculopathy.
Koskinen PK; Kallio EA; Tikkanen JM; Sihvola RK; Häyry PJ; Lemström KB
Transpl Infect Dis; 1999 Jun; 1(2):115-26. PubMed ID: 11428979
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts.
Koskinen PK; Kallio EA; Bruggeman CA; Lemström KB
Am J Respir Crit Care Med; 1997 Jun; 155(6):2078-88. PubMed ID: 9196118
[TBL] [Abstract][Full Text] [Related]
17. Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats.
Lemström K; Bruning J; Koskinen P; Bruggeman C; Lautenschlager I; Häyry P
Transplant Proc; 1994 Jun; 26(3):1727-8. PubMed ID: 8030105
[No Abstract] [Full Text] [Related]
18. Effects of acute cytomegalovirus infection on rat islet allograft survival.
Smelt MJ; de Haan BJ; Faas MM; Melgert BN; de Haan A; de Vos P
Cell Transplant; 2011; 20(8):1271-83. PubMed ID: 21176406
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection enhances allograft arteriosclerosis in the rat.
Lemström K; Persoons M; Bruggeman C; Ustinov J; Lautenschlager I; Häyry P
Transplant Proc; 1993 Feb; 25(1 Pt 2):1406-7. PubMed ID: 8382862
[No Abstract] [Full Text] [Related]
20. Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat.
Lautenschlager I; Soots A; Krogerus L; Kauppinen H; Saarinen O; Bruggeman C; Ahonen J
Transplantation; 1997 Aug; 64(3):391-8. PubMed ID: 9275101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
